{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T04:01:47Z","timestamp":1785816107314,"version":"3.56.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2021,5,26]],"date-time":"2021-05-26T00:00:00Z","timestamp":1621987200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,5,26]],"date-time":"2021-05-26T00:00:00Z","timestamp":1621987200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Calcif Tissue Int"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1007\/s00223-021-00869-6","type":"journal-article","created":{"date-parts":[[2021,5,26]],"date-time":"2021-05-26T12:02:43Z","timestamp":1622030563000},"page":"544-553","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Bone Density After Teriparatide Discontinuation With or Without Antiresorptive Therapy in Pregnancy- and Lactation-Associated Osteoporosis"],"prefix":"10.1007","volume":"109","author":[{"given":"Seunghyun","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Namki","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyoung Jin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chung Hyun","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jooyeon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4227-5638","authenticated-orcid":false,"given":"Yumie","family":"Rhee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,5,26]]},"reference":[{"key":"869_CR1","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1002\/jbmr.3750","volume":"34","author":"A Cohen","year":"2019","unstructured":"Cohen A, Kamanda-Kosseh M, Dempster DW, Zhou H, M\u00fcller R, Goff E, Colon I, Bucovsky M, Stubby J, Nickolas TL, Stein EM, Recker RR, Lappe JM, Shane E (2019) Women With Pregnancy and Lactation-Associated Osteoporosis (PLO) Have Low Bone Remodeling Rates at the Tissue Level. J Bone Miner Res 34:1552\u20131561","journal-title":"J Bone Miner Res"},{"key":"869_CR2","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/S0140-6736(55)90214-2","volume":"265","author":"BEC Nordin","year":"1955","unstructured":"Nordin BEC, Roper A (1955) POST-PREGNANCY OSTEOPOROSIS A SYNDROME\u202f? The Lancet 265:431\u2013434","journal-title":"The Lancet"},{"key":"869_CR3","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1007\/s001980070113","volume":"11","author":"AJ Phillips","year":"2000","unstructured":"Phillips AJ, Ostlere SJ, Smith R (2000) Pregnancy-Associated Osteoporosis: Does the Skeleton Recover? Osteoporos Int 11:449\u2013454","journal-title":"Osteoporos Int"},{"key":"869_CR4","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1007\/s12018-019-09262-2","volume":"17","author":"N Hong","year":"2019","unstructured":"Hong N, Rhee Y (2019) Comparison of Efficacy of Pharmacologic Treatments in Pregnancy- and Lactation-Associated Osteoporosis. Clinical Reviews in Bone and Mineral Metabolism 17:86\u201393","journal-title":"Clinical Reviews in Bone and Mineral Metabolism"},{"key":"869_CR5","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1097\/MED.0000000000000102","volume":"21","author":"CS Kovacs","year":"2014","unstructured":"Kovacs CS (2014) Osteoporosis presenting in pregnancy, puerperium, and lactation. Curr Opin Endocrinol Diabetes Obes 21:468\u2013475","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"869_CR6","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s00198-017-4239-1","volume":"29","author":"I Kyvernitakis","year":"2018","unstructured":"Kyvernitakis I, Reuter TC, Hellmeyer L, Hars O, Hadji P (2018) Subsequent fracture risk of women with pregnancy and lactation-associated osteoporosis after a median of 6 years of follow-up. Osteoporos Int 29:135\u2013142","journal-title":"Osteoporos Int"},{"key":"869_CR7","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1111\/cen.13557","volume":"88","author":"N Hong","year":"2018","unstructured":"Hong N, Kim JE, Lee SJ, Kim SH, Rhee Y (2018) Changes in bone mineral density and bone turnover markers during treatment with teriparatide in pregnancy-and lactation-associated osteoporosis. Clin Endocrinol 88:652\u2013658","journal-title":"Clin Endocrinol"},{"key":"869_CR8","doi-asserted-by":"publisher","first-page":"3135","DOI":"10.1007\/s00198-017-4165-2","volume":"28","author":"M Laroche","year":"2017","unstructured":"Laroche M, Talibart M, Cormier C, Roux C, Guggenbuhl P, Degboe Y (2017) Pregnancy-related fractures: a retrospective study of a French cohort of 52 patients and review of the literature. Osteoporos Int 28:3135\u20133142","journal-title":"Osteoporos Int"},{"key":"869_CR9","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1007\/s00198-006-0112-3","volume":"17","author":"SM O\u2019Sullivan","year":"2006","unstructured":"O\u2019Sullivan SM, Grey AB, Singh R, Reid IR (2006) Bisphosphonates in pregnancy and lactation-associated osteoporosis. Osteoporos Int 17:1008\u20131012","journal-title":"Osteoporos Int"},{"key":"869_CR10","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1002\/(SICI)1096-9926(199908)60:2<68::AID-TERA10>3.0.CO;2-H","volume":"60","author":"N Patlas","year":"1999","unstructured":"Patlas N, Golomb G, Yaffe P, Pinto T, Breuer E, Ornoy A (1999) Transplacental effects of bisphosphonates on fetal skeletal ossification and mineralization in rats. Teratology 60:68\u201373","journal-title":"Teratology"},{"key":"869_CR11","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1359\/jbmr.1997.12.10.1700","volume":"12","author":"SA Khan","year":"1997","unstructured":"Khan SA, Kanis JA, Vasikaran S, Kline WF, Matuszewski BK, McCloskey EV, Beneton MNC, Gertz BJ, Sciberras DG, Holland SD, Orgee J, Coombes GM, Rogers SR, Porras AG (1997) Elimination and Biochemical Responses to Intravenous Alendronate in Postmenopausal Osteoporosis. J Bone Miner Res 12:1700\u20131707","journal-title":"J Bone Miner Res"},{"key":"869_CR12","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1056\/NEJMc062792","volume":"356","author":"SE Papapoulos","year":"2007","unstructured":"Papapoulos SE, Cremers SCLM (2007) Prolonged Bisphosphonate Release after Treatment in Children. N Engl J Med 356:1075\u20131076","journal-title":"N Engl J Med"},{"key":"869_CR13","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1210\/jc.2019-00221","volume":"104","author":"CJR Richard Eastell","year":"2019","unstructured":"Richard Eastell CJR, Black DM, Cheung AM, Hassan Murad M, Shoback D (2019) Pharmacological Management of Osteoporosis in Postmenopausal Women\u202f: An Endocrine Society Clinical Practice Guideline. The Journal of Clinical Endocriniology & Metabolism 104:1595\u20131622","journal-title":"The Journal of Clinical Endocriniology & Metabolism"},{"key":"869_CR14","doi-asserted-by":"publisher","first-page":"195","DOI":"10.2147\/TCRM.S30668","volume":"8","author":"J Iwamoto","year":"2012","unstructured":"Iwamoto J, Sato Y, Uzawa M, Matsumoto H (2012) Five-year follow-up of a woman with pregnancy and lactation-associated osteoporosis and vertebral fractures. Ther Clin Risk Manag 8:195\u2013199","journal-title":"Ther Clin Risk Manag"},{"key":"869_CR15","doi-asserted-by":"publisher","first-page":"495","DOI":"10.14310\/horm.2002.1383","volume":"11","author":"K Lampropoulou-Adamidou","year":"2012","unstructured":"Lampropoulou-Adamidou K, Trovas G, Stathopoulos IP, Papaioannou NA (2012) Case report: teriparatide treatment in a case of severe pregnancy-and lactation-associated osteoporosis. Hormones 11:495\u2013500","journal-title":"Hormones"},{"key":"869_CR16","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1007\/s00774-011-0334-0","volume":"30","author":"EY Choe","year":"2012","unstructured":"Choe EY, Song JE, Park KH, Seok H, Lee EJ, Lim S-K, Rhee Y (2012) Effect of teriparatide on pregnancy and lactation-associated osteoporosis with multiple vertebral fractures. J Bone Miner Metab 30:596\u2013601","journal-title":"J Bone Miner Metab"},{"key":"869_CR17","doi-asserted-by":"publisher","first-page":"725","DOI":"10.3109\/09513591003649831","volume":"26","author":"L Hellmeyer","year":"2010","unstructured":"Hellmeyer L, Boekhoff J, Hadji P (2010) Treatment with teriparatide in a patient with pregnancy-associated osteoporosis. Gynecol Endocrinol 26:725\u2013728","journal-title":"Gynecol Endocrinol"},{"key":"869_CR18","doi-asserted-by":"publisher","first-page":"522","DOI":"10.3109\/09513590.2015.1014787","volume":"31","author":"SB Polat","year":"2015","unstructured":"Polat SB, Evranos B, Aydin C, Cuhaci N, Ersoy R, Cakir B (2015) Effective treatment of severe pregnancy and lactation-related osteoporosis with teriparatide: case report and review of the literature. Gynecol Endocrinol 31:522\u2013525","journal-title":"Gynecol Endocrinol"},{"key":"869_CR19","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1016\/j.tjog.2017.10.028","volume":"56","author":"A Ijuin","year":"2017","unstructured":"Ijuin A, Yoshikata H, Asano R, Tsuburai T, Kikuchi R, Sakakibara H (2017) Teriparatide and denosumab treatment for pregnancy and lactation-associated osteoporosis with multiple vertebral fractures: a case study. Taiwan J Obstet Gynecol 56:863\u2013866","journal-title":"Taiwan J Obstet Gynecol"},{"key":"869_CR20","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1359\/jbmr.040117","volume":"19","author":"B Ettinger","year":"2004","unstructured":"Ettinger B, Martin SJ, Crans G, Pavo I (2004) Differential Effects of Teriparatide on BMD After Treatment With Raloxifene or Alendronate. J Bone Miner Res 19:745\u2013751","journal-title":"J Bone Miner Res"},{"key":"869_CR21","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1359\/jbmr.080506","volume":"23","author":"BM Obermayer-Pietsch","year":"2008","unstructured":"Obermayer-Pietsch BM, Marin F, McCloskey EV, Hadji P, Farrerons J, Boonen S, Audran M, Barker C, Anastasilakis AD, Fraser WD, Nickelsen T (2008) Effects of Two Years of Daily Teriparatide Treatment on BMD in Postmenopausal Women With Severe Osteoporosis With and Without Prior Antiresorptive Treatment. J Bone Miner Res 23:1591\u20131600","journal-title":"J Bone Miner Res"},{"key":"869_CR22","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1016\/S0140-6736(15)61120-5","volume":"386","author":"BZ Leder","year":"2015","unstructured":"Leder BZ, Tsai JN, Uihlein AV, Wallace PM, Lee H, Neer RM, Burnett-Bowie S-AM (2015) Denosumab and teriparatide transitions in postmenopausal osteoporosis (the DATA-Switch study): extension of a randomised controlled trial. The Lancet 386:1147\u20131155","journal-title":"The Lancet"},{"key":"869_CR23","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1002\/jbmr.3051","volume":"32","author":"F Cosman","year":"2017","unstructured":"Cosman F, Nieves JW, Dempster DW (2017) Treatment Sequence Matters: Anabolic and Antiresorptive Therapy for Osteoporosis. J Bone Miner Res 32:198\u2013202","journal-title":"J Bone Miner Res"},{"key":"869_CR24","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/S0025-6196(11)60752-0","volume":"84","author":"KA Kennel","year":"2009","unstructured":"Kennel KA, Drake MT (2009) Adverse effects of bisphosphonates: implications for osteoporosis management. Mayo Clin Proc 84:632\u2013638","journal-title":"Mayo Clin Proc"},{"key":"869_CR25","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","volume":"150","author":"AS Levey","year":"2009","unstructured":"Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T (2009) A new equation to estimate glomerular filtration rate. Ann Intern Med 150:604\u2013612","journal-title":"Ann Intern Med"},{"key":"869_CR26","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/BF01063556","volume":"18","author":"KF Phillips","year":"1990","unstructured":"Phillips KF (1990) Power of the two one-sided tests procedure in bioequivalence. J Pharmacokinet Biopharm 18:137\u2013144","journal-title":"J Pharmacokinet Biopharm"},{"key":"869_CR27","first-page":"94","volume":"52","author":"UC Stumpf","year":"2007","unstructured":"Stumpf UC, Kurth AA, Windolf J, Fassbender WJ (2007) Pregnancy-associated osteoporosis: an underestimated and underdiagnosed severe disease. A review of two cases in short- and long-term follow-up. Adv Med Sci 52:94\u201397","journal-title":"Adv Med Sci"},{"key":"869_CR28","doi-asserted-by":"publisher","first-page":"736","DOI":"10.3109\/01443615.2014.920800","volume":"34","author":"I Coskun Benlidayi","year":"2014","unstructured":"Coskun Benlidayi I, Sarpel T, Guzel R (2014) Short-term treatment experience with teriparatide in pregnancy- and lactation-associated osteoporosis. J Obstet Gynaecol 34:736","journal-title":"J Obstet Gynaecol"},{"key":"869_CR29","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1093\/rheumatology\/33.3.269","volume":"33","author":"J Blanch","year":"1994","unstructured":"Blanch J, Pacifici R, Chines A (1994) Pregnancy-associated osteoporosis: report of two cases with long-term bone density follow-up. Br J Rheumatol 33:269\u2013272","journal-title":"Br J Rheumatol"},{"key":"869_CR30","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1111\/j.1447-0756.1999.tb01124.x","volume":"25","author":"T Anai","year":"1999","unstructured":"Anai T, Tomiyasu T, Arima K, Miyakawa I (1999) Pregnancy-associated osteoporosis with elevated levels of circulating parathyroid hormone-related protein: a report of two cases. J Obstet Gynaecol Res 25:63\u201367","journal-title":"J Obstet Gynaecol Res"},{"key":"869_CR31","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/BF02249031","volume":"13","author":"OL Rillo","year":"1994","unstructured":"Rillo OL, Di Stefano CA, Bermudez J, Maldonado Cocco JA (1994) Idiopathic osteoporosis during pregnancy. Clin Rheumatol 13:299\u2013304","journal-title":"Clin Rheumatol"},{"key":"869_CR32","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1067\/mob.2001.113910","volume":"185","author":"S Honjo","year":"2001","unstructured":"Honjo S, Mizunuma H (2001) Changes in biochemical parameters of bone turnover and bone mineral density in post-pregnancy osteoporosis. Am J Obstet Gynecol 185:246\u2013247","journal-title":"Am J Obstet Gynecol"},{"key":"869_CR33","doi-asserted-by":"crossref","unstructured":"Zhang M, Chen P, Li B, Du J, Pan T, Chen J (2017) Approach to the patient with pregnancy and lactation-associated osteoporosis: a case report and a review of the literature. Medicine (Baltimore) 96:e8671","DOI":"10.1097\/MD.0000000000008671"},{"key":"869_CR34","doi-asserted-by":"publisher","first-page":"2223","DOI":"10.1007\/s00198-015-3149-3","volume":"26","author":"CS Kovacs","year":"2015","unstructured":"Kovacs CS, Ralston SH (2015) Presentation and management of osteoporosis presenting in association with pregnancy or lactation. Osteoporos Int 26:2223\u20132241","journal-title":"Osteoporos Int"},{"key":"869_CR35","doi-asserted-by":"publisher","first-page":"R143","DOI":"10.1530\/EC-20-0055","volume":"9","author":"EM Winter","year":"2020","unstructured":"Winter EM, Ireland A, Butterfield NC, Haffner-Luntzer M, Horcajada MN, Veldhuis-Vlug AG, Oei L, Colaianni G, Bonnet N (2020) Pregnancy and lactation, a challenge for the skeleton. Endocr Connect 9:R143-r157","journal-title":"Endocr Connect"},{"key":"869_CR36","doi-asserted-by":"publisher","first-page":"5521","DOI":"10.1210\/en.2003-0892","volume":"144","author":"JN VanHouten","year":"2003","unstructured":"VanHouten JN, Wysolmerski JJ (2003) Low Estrogen and High Parathyroid Hormone-Related Peptide Levels Contribute to Accelerated Bone Resorption and Bone Loss in Lactating Mice. Endocrinology 144:5521\u20135529","journal-title":"Endocrinology"},{"key":"869_CR37","doi-asserted-by":"publisher","first-page":"4010","DOI":"10.1210\/en.2005-1616","volume":"147","author":"JP Woodrow","year":"2006","unstructured":"Woodrow JP, Sharpe CJ, Fudge NJ, Hoff AO, Gagel RF, Kovacs CS (2006) Calcitonin plays a critical role in regulating skeletal mineral metabolism during lactation. Endocrinology 147:4010\u20134021","journal-title":"Endocrinology"},{"key":"869_CR38","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1007\/s00198-019-05236-8","volume":"31","author":"FMF Grizzo","year":"2020","unstructured":"Grizzo FMF, Alarc\u00e3o ACJ, Dell\u2019 Agnolo CM, Pedroso RB, Santos TS, Vissoci JRN, Pinheiro MM, Carvalho MDB, Pelloso SM, (2020) How does women\u2019s bone health recover after lactation? A systematic review and meta-analysis. Osteoporos Int 31:413\u2013427","journal-title":"Osteoporos Int"},{"key":"869_CR39","doi-asserted-by":"publisher","first-page":"4208","DOI":"10.1210\/jc.2015-2829","volume":"100","author":"A Cohen","year":"2015","unstructured":"Cohen A, Kamanda-Kosseh M, Recker RR, Lappe JM, Dempster DW, Zhou H, Cremers S, Bucovsky M, Stubby J, Shane E (2015) Bone density after teriparatide discontinuation in premenopausal idiopathic osteoporosis. J Clin Endocrinol Metab 100:4208\u20134214","journal-title":"J Clin Endocrinol Metab"},{"key":"869_CR40","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1007\/s00198-004-1716-0","volume":"16","author":"MR Rubin","year":"2005","unstructured":"Rubin MR, Schussheim DH, Kulak CA, Kurland ES, Rosen CJ, Bilezikian JP, Shane E (2005) Idiopathic osteoporosis in premenopausal women. Osteoporos Int 16:526\u2013533","journal-title":"Osteoporos Int"},{"key":"869_CR41","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1055\/s-2004-815725","volume":"112","author":"CE Pepene","year":"2004","unstructured":"Pepene CE, Seck T, Diel I, Minne HW, Ziegler R, Pfeilschifter J (2004) Concentration of insulin-like growth factor (IGF)-I in iliac crest bone matrix in premenopausal women with idiopathic osteoporosis. Exp Clin Endocrinol Diabetes 112:38\u201343","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"869_CR42","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1002\/jbmr.5650100812","volume":"10","author":"BY Reed","year":"1995","unstructured":"Reed BY, Zerwekh JE, Sakhaee K, Breslau NA, Gottschalk F, Pak CYC (1995) Serum IGF 1 is low and correlated with osteoblastic surface in idiopathic osteoporosis. J Bone Miner Res 10:1218\u20131224","journal-title":"J Bone Miner Res"},{"key":"869_CR43","doi-asserted-by":"publisher","first-page":"3095","DOI":"10.1210\/jc.2011-1387","volume":"96","author":"A Cohen","year":"2011","unstructured":"Cohen A, Dempster DW, Recker RR, Stein EM, Lappe JM, Zhou H, Wirth AJ, van Lenthe GH, Kohler T, Zwahlen A, M\u00fcller R, Rosen CJ, Cremers S, Nickolas TL, McMahon DJ, Rogers H, Staron RB, LeMaster J, Shane E (2011) Abnormal bone microarchitecture and evidence of osteoblast dysfunction in premenopausal women with idiopathic osteoporosis. J Clin Endocrinol Metab 96:3095\u20133105","journal-title":"J Clin Endocrinol Metab"},{"key":"869_CR44","doi-asserted-by":"publisher","first-page":"3575","DOI":"10.1007\/s10067-019-04758-0","volume":"38","author":"M Gehlen","year":"2019","unstructured":"Gehlen M, Lazarescu AD, Hinz C, Schwarz-Eywill M, Pfeifer M, Balasingam S, Maier A (2019) Long-term outcome of patients with pregnancy and lactation-associated osteoporosis (PLO) with a particular focus on quality of life. Clin Rheumatol 38:3575\u20133583","journal-title":"Clin Rheumatol"},{"key":"869_CR45","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1007\/s00198-019-04842-w","volume":"30","author":"S Hardcastle","year":"2019","unstructured":"Hardcastle S, Yahya F, Bhalla A (2019) Pregnancy-associated osteoporosis: a UK case series and literature review. Osteoporos Int 30:939\u2013948","journal-title":"Osteoporos Int"},{"key":"869_CR46","unstructured":"Smith R, Athanasou NA, Ostlere SJ, Vipond SE (1995) Pregnancy-associated osteoporosis. QJM 88:865\u2013878"},{"key":"869_CR47","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/nrrheum.2012.86","volume":"8","author":"K Naylor","year":"2012","unstructured":"Naylor K, Eastell R (2012) Bone turnover markers: use in osteoporosis. Nat Rev Rheumatol 8:379\u2013389","journal-title":"Nat Rev Rheumatol"}],"container-title":["Calcified Tissue International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-021-00869-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00223-021-00869-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-021-00869-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,30]],"date-time":"2021-09-30T12:11:33Z","timestamp":1633003893000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00223-021-00869-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,26]]},"references-count":47,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["869"],"URL":"https:\/\/doi.org\/10.1007\/s00223-021-00869-6","relation":{},"ISSN":["0171-967X","1432-0827"],"issn-type":[{"value":"0171-967X","type":"print"},{"value":"1432-0827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,26]]},"assertion":[{"value":"16 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Y. Rhee has served as a consultant for Amgen and has received honorarium from Amgen. Seunghyun Lee, Namki Hong, Kyoung Jin Kim, Chung Hyun Park, and Jooyeon Lee have no relevant disclosures.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the Institutional Review Board of Severance Hospital.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}}]}}